Co-diagnostics Inc.(CODX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CODX Co-diagnostics Inc.

Closed 11-22 16:00:00 EST

1.01

-0.05

-4.72%

盘后1.02

+0.01+0.99%

19:58 EST

High1.06	Low1.00	Vol172.03K
Open1.06	D1 Closing1.06	Amplitude5.66%
Mkt Cap32.25M	Tradable Cap30.51M	Total Shares31.93M
T/O177.14K	T/O Rate0.57%	Tradable Shares30.21M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"CODX","market":"US","secType":"STK","nameCN":"Co-diagnostics Inc.","latestPrice":1.01,"timestamp":1732309200000,"preClose":1.06,"halted":0,"volume":172030,"hourTrading":{"tag":"盘后","latestPrice":1.02,"preClose":1.01,"latestTime":"19:58 EST","volume":1271,"amount":1302.99,"timestamp":1732323538048},"delay":0,"floatShares":30206040,"shares":31929752,"eps":-1.37692,"marketStatus":"Closed","change":-0.05,"latestTime":"11-22 16:00:00 EST","open":1.06,"high":1.06,"low":1,"amount":177138.207211,"amplitude":0.056604,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.37692,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1732525200000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":1.06,"preHourTrading":{"tag":"盘前","latestPrice":1.05,"preClose":1.06,"latestTime":"09:22 EST","volume":58,"amount":60.4099986,"timestamp":1732285335347},"postHourTrading":{"tag":"盘后","latestPrice":1.02,"preClose":1.01,"latestTime":"19:58 EST","volume":1271,"amount":1302.99,"timestamp":1732323538048},"volumeRatio":1.334893,"impliedVol":1.1218,"impliedVolPercentile":0.5397},"requestUrl":"/m/hq/s/CODX/tweets","defaultTab":"tweets","newsList":[{"id":"2482563200","title":"Co-Diagnostics Price Target Maintained With a $1.50/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2482563200","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482563200?lang=en_us&edition=fundamental","pubTime":"2024-11-11 19:55","pubTimestamp":1731326100,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CODX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 11, 2024 06:55 ET (11:55 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CODX"],"gpt_icon":0},{"id":"2482263105","title":"Co-Diagnostics Third Quarter 2024 Earnings: Beats Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2482263105","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482263105?lang=en_us&edition=fundamental","pubTime":"2024-11-10 20:30","pubTimestamp":1731241816,"startTime":"0","endTime":"0","summary":"NasdaqCM:CODX Earnings and Revenue Growth November 10th 2024. All figures shown in the chart above are for the trailing 12 month  period. Revenue exceeded analyst estimates by 71%. Earnings per share  also surpassed analyst estimates by 3.0%.Looking ahead, revenue is expected to decline by 95% p.a. on average during the next 2 years, while revenues in the Medical Equipment industry in the US are expected to grow by 8.3%.The company's shares are down 5.8% from a week ago.We don't want to rain on the parade too much, but we did also find 5 warning signs for Co-Diagnostics (1 makes us a bit uncomfortable!) that you need to be mindful of.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/co-diagnostics-third-quarter-2024-123016218.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CODX"],"gpt_icon":0},{"id":"2481100539","title":"Co-Diagnostics Inc (CODX) Q3 2024 Earnings Call Highlights: Navigating Revenue Decline and ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2481100539","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481100539?lang=en_us&edition=fundamental","pubTime":"2024-11-08 23:03","pubTimestamp":1731078191,"startTime":"0","endTime":"0","summary":"Total Revenue: $0.6 million, down from $2.5 million in the prior year same period.Grant Revenue: $0.4 million in the third quarter of 2024.Product Revenue: $0.2 million in the third quarter of 2024.Gross Profit: $0.3 million, compared to $2.2 million in the prior year comparable period.Total Operating Expenses: $10.6 million, decreased from $11.1 million in the third quarter of 2023.Research and Development Expenses: $4.9 million, compared to $5.8 million in the prior year period.Income Before Taxes: Loss of $9.7 million, compared to a loss of $8.1 million in the prior year.Net Loss: $9.7 million or $0.32 per fully diluted share, compared to a net loss of $6.0 million or $0.20 per fully diluted share in the prior year.Adjusted EBITDA: Loss of $8.8 million, compared to a loss of $6.5 million in the prior year.Cash, Cash Equivalents, and Marketable Investment Securities: $37.7 million at the end of the quarter.GuruFocus has detected 5 Warning Signs with CODX.Co-Diagnostics Inc  has made ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/gY1zAyP_yM8I1zhtICTwBw--~B/aD0yNDM7dz0yNDM7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/ba002a6338b45ced3986505d6cb81cff","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/gY1zAyP_yM8I1zhtICTwBw--~B/aD0yNDM7dz0yNDM7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/ba002a6338b45ced3986505d6cb81cff"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/co-diagnostics-inc-codx-q3-150311032.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CODX"],"gpt_icon":0},{"id":"2481190660","title":"Co-Diagnostics Inc reports results for the quarter ended in September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2481190660","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481190660?lang=en_us&edition=fundamental","pubTime":"2024-11-08 12:58","pubTimestamp":1731041939,"startTime":"0","endTime":"0","summary":"* Co-Diagnostics Inc    reported a quarterly adjusted loss of 32 cents per share for the quarter ended September 30, lower than the same quarter last year, when the company reported EPS of -20 cents. ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CODX"],"gpt_icon":0},{"id":"2481500941","title":"Co-Diagnostics Q3 2024 GAAP EPS $(0.32) Beats $(0.33) Estimate, Sales $641.141K Beat $375.000K Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2481500941","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481500941?lang=en_us&edition=fundamental","pubTime":"2024-11-08 05:59","pubTimestamp":1731016795,"startTime":"0","endTime":"0","summary":"Co-Diagnostics (NASDAQ:CODX) reported quarterly losses of $(0.32) per share which beat the analyst consensus estimate of $(0.33) by 3.03 percent. This is a 60 percent decrease over losses of $(0.20) per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/41826969/co-diagnostics-q3-2024-gaap-eps-0-32-beats-0-33-estimate-sales-641-141k-beat-375-000k-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Co-Diagnostics Q3 2024 GAAP EPS $(0.32) Beats $(0.33) Estimate, Sales $641.141K Beat $375.000K Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CODX"],"gpt_icon":0},{"id":"2481151522","title":"Co-Diagnostics Q3 Revenue USD 600 Thousand","url":"https://stock-news.laohu8.com/highlight/detail?id=2481151522","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481151522?lang=en_us&edition=fundamental","pubTime":"2024-11-08 05:01","pubTimestamp":1731013268,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241107:nPLX690139:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","CODX","BK4568"],"gpt_icon":0},{"id":"2481193552","title":"Co-Diagnostics, Inc. Reports Third Quarter 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2481193552","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481193552?lang=en_us&edition=fundamental","pubTime":"2024-11-08 05:01","pubTimestamp":1731013260,"startTime":"0","endTime":"0","summary":"SALT LAKE CITY, Nov. 7, 2024 /PRNewswire/ --Co-Diagnostics, Inc., a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced financial results for the quarter ended September 30, 2024.Revenue of $0.6 million, which declined from $2.5 million during the prior year primarily due to timing of grant revenue recognition. Grant revenue totaled $0.4 million while product revenue totaled $0.2 million. Operating expenses of $10.6 million decreased by 5.0% from the prior year due to higher expenses in 2023 related to platform development and regulatory submission preparation. Net loss of $9.7 million, compared to net loss of $6.0 million in the prior year, representing a loss of $0.32 per fully diluted share, compared to a loss of $0.20 per fully diluted share in the prior year. \"Co-Diagnostics has made significant progress on our tests, and look forward to providing you with regulatory and commercialization updates as they","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/KX2Pnj8YuhduS5XB_xAscA--~B/aD0xODQ7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/7a89e790bf1cbdd13a473c00e9766ccb","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/KX2Pnj8YuhduS5XB_xAscA--~B/aD0xODQ7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/7a89e790bf1cbdd13a473c00e9766ccb"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/co-diagnostics-inc-reports-third-210100037.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/co-diagnostics-inc-reports-third-210100037.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CODX","WRD","BK4568","BK4082"],"gpt_icon":0},{"id":"2481168813","title":"Co-Diagnostics, Inc. to Host Booth at MEDICA Trade Fair in Düsseldorf, Germany on Nov 11-14, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2481168813","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481168813?lang=en_us&edition=fundamental","pubTime":"2024-11-05 22:30","pubTimestamp":1730817000,"startTime":"0","endTime":"0","summary":"SALT LAKE CITY, Nov. 5, 2024 /PRNewswire/ -- Co-Diagnostics, Inc.  , a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be hosting a booth and delivering a presentation at the MEDICA 2024 trade fair in Düsseldorf, Germany on November 11-14.MEDICA has become the largest medical B2B trade fair in the world, attracting 83,000 visitors and over 5,300 exhibitors from almost 70 countries. The Company expects to use the opportunity to generate increased interest in its suite of PCR in vitro diagnostic and research products for infectious diseases, and to introduce and promote its Co-Primers technology and applications to a wide audience of international attendees.About Co-Diagnostics, Inc.:Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets state-of-the-art diagnostics technologies. The Company's technologies are utilized for tests that","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/KX2Pnj8YuhduS5XB_xAscA--~B/aD0xODQ7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/7a89e790bf1cbdd13a473c00e9766ccb","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/KX2Pnj8YuhduS5XB_xAscA--~B/aD0xODQ7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/7a89e790bf1cbdd13a473c00e9766ccb"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/co-diagnostics-inc-host-booth-143000990.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/co-diagnostics-inc-host-booth-143000990.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4568","BK4218","BK4181","BK4588","BK4082","HST","CODX","BK4585"],"gpt_icon":0},{"id":"2479081750","title":"Is Co-Diagnostics (NASDAQ:CODX) In A Good Position To Deliver On Growth Plans?","url":"https://stock-news.laohu8.com/highlight/detail?id=2479081750","media":"Simply Wall St.","labels":["Business Data"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479081750?lang=en_us&edition=fundamental","pubTime":"2024-10-31 20:45","pubTimestamp":1730378730,"startTime":"0","endTime":"0","summary":"Just because a business does not make any money, does not mean that the stock will go down. For example, although Amazon.com made losses for many years after listing, if you had bought and held the shares since 1999, you would have made a fortune. But while the successes are well known, investors should not ignore the very many unprofitable companies that simply burn through all their cash and collapse.So should Co-Diagnostics  shareholders be worried about its cash burn?In this article, we define cash burn as its annual  free cash flow, which is the amount of money a company spends each year to fund its growth. First, we'll determine its cash runway by comparing its cash burn with its cash reserves.Since it has a market capitalisation of US$39m, Co-Diagnostics' US$25m in cash burn equates to about 66% of","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/qrnhoA9Y9l_fYJBd0ck5WA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/qrnhoA9Y9l_fYJBd0ck5WA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/co-diagnostics-nasdaq-codx-good-124530870.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Business Data","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["QID","IE00B3QW5Z07.USD","TQQQ","BK4568","BK4588","LU2210150020.SGD","IE00B64PRP62.GBP",".IXIC","BK4082","BK4112","SQQQ","IE00BGHQF748.EUR","PSQ","NQmain","NDAQ","MNQmain","QLD","LU2095319765.USD","BK4585","IE00BKPKM429.USD","CODX","LU2210149790.SGD"],"gpt_icon":1},{"id":"2478694959","title":"Co-Diagnostics, Inc. Announces Third Quarter 2024 Earnings Release Date and Webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2478694959","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2478694959?lang=en_us&edition=fundamental","pubTime":"2024-10-26 04:01","pubTimestamp":1729886460,"startTime":"0","endTime":"0","summary":"SALT LAKE CITY, Oct. 25, 2024 /PRNewswire/ -- Co-Diagnostics, Inc., a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its third quarter 2024 results on Thursday, November 7, 2024, after the market close. The Company will also host a conference call and webcast on the same day at 4:30 p.m. ET to discuss its financial results with analysts and institutional investors. Management on the call will include Dwight Egan, Chief Executive Officer, Brian Brown, Chief Financial Officer, and Andrew Benson, Head of Investor Relations.The conference call and webcast will be available via:. If you are unable to participate during the live webcast, the call will be recorded and later made available on the Company's website.About Co-Diagnostics, Inc.Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets state-of-the-art diagnostics technologies.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/KX2Pnj8YuhduS5XB_xAscA--~B/aD0xODQ7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/7a89e790bf1cbdd13a473c00e9766ccb","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/KX2Pnj8YuhduS5XB_xAscA--~B/aD0xODQ7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/7a89e790bf1cbdd13a473c00e9766ccb"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/co-diagnostics-inc-announces-third-200100624.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/co-diagnostics-inc-announces-third-200100624.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CODX"],"gpt_icon":0},{"id":"2477863672","title":"Co-Diagnostics, Inc. to Host Booth at Medlab Africa in Cape Town on Oct 22-24, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2477863672","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477863672?lang=en_us&edition=fundamental","pubTime":"2024-10-21 21:30","pubTimestamp":1729517400,"startTime":"0","endTime":"0","summary":"SALT LAKE CITY, Oct. 21, 2024 /PRNewswire/ -- Co-Diagnostics, Inc.  , a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that Co-Diagnostics will be hosting a booth at Africa Health/Medlab Africa in Cape Town, South Africa on October 22-24, 2024.Co-Dx believes that the trade show will contribute valuable insight into markets that are anticipated to play an important role in the Company's future. In a report issued in September 2023, the WHO estimated that 2.5 million people contracted tuberculosis  in the African Region in 2021, while noting that a large gap also remains between estimated TB cases and those identified. Co-Dx has several infectious disease tests in varying stages of development on the Company's upcoming Co-Dx PCR at-home and point-of-care platform*, including a test for TB.Forward-Looking Statements:This press release contains forward-looking statementswithin the meaning of the Private Secu","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/KX2Pnj8YuhduS5XB_xAscA--~B/aD0xODQ7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/7a89e790bf1cbdd13a473c00e9766ccb","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/KX2Pnj8YuhduS5XB_xAscA--~B/aD0xODQ7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/7a89e790bf1cbdd13a473c00e9766ccb"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/co-diagnostics-inc-host-booth-133000181.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/co-diagnostics-inc-host-booth-133000181.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4181","BK4588","BK4585","BK4218","BK4082","HST","CODX","BK4568"],"gpt_icon":0},{"id":"2474263777","title":"Alignment HealthCare Partners With Intermountain Health in Nevada","url":"https://stock-news.laohu8.com/highlight/detail?id=2474263777","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474263777?lang=en_us&edition=fundamental","pubTime":"2024-10-10 22:10","pubTimestamp":1728569400,"startTime":"0","endTime":"0","summary":"Alignment HealthCare, Inc.’s ALHC leading Medicare Advantage plan, Alignment Health Plan, is expanding its healthcare services in Nevada through a new agreement with Intermountain Health. Beginning Jan. 1, 2025, the partnership will give Medicare members in Clark and Washoe counties access to over 65 clinic locations, including 35 award-winning senior primary care clinics. This collaboration promises to enhance the level of care available to Nevada’s growing senior population.Alignment HealthCare, known for its mission-driven approach to providing high-quality, affordable care for Medicare Advantage members, collaborates with trusted providers to deliver coordinated, personalized care. Intermountain Health, a nonprofit system with 33 hospitals and 385 clinics across six states, is recognized for its leadership in transforming healthcare through evidence-based practices and community health initiatives. This partnership aims to provide expanded healthcare services to Nevada's senior pop","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/ZcqDt7bCeBMLkGs_KJ1O8A--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/228e67967b066e7a755ae3614be720e1","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/ZcqDt7bCeBMLkGs_KJ1O8A--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/228e67967b066e7a755ae3614be720e1"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/alignment-healthcare-partners-intermountain-health-141000515.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ICCM","ALHC","LU1169590202.USD","BK4539","LU2065731478.USD","BK4154","LU1169589451.USD","BK4568","CODX","BK4082","HQY"],"gpt_icon":0},{"id":"2474333785","title":"Co-Diagnostics Inc (CODX) Q2 2024 Earnings Call Highlights: Revenue Surge Amidst Regulatory Hurdles","url":"https://stock-news.laohu8.com/highlight/detail?id=2474333785","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474333785?lang=en_us&edition=fundamental","pubTime":"2024-10-10 05:58","pubTimestamp":1728511124,"startTime":"0","endTime":"0","summary":"Total Revenue: $2.7 million, up from $0.2 million in the prior year same period.Grant Revenue: $2.5 million in the second quarter of 2024.Product Revenue: $0.2 million in the second quarter of 2024.Gross Profit: $2.4 million, compared to negative $0.3 million in the prior year comparable period.Total Operating Expenses: Decreased to $10.1 million from $11.7 million in the second quarter of 2023.Research and Development Expenses: $5.6 million, down from $6.0 million in the prior year period.Income Before Taxes: Loss of $7.7 million, compared to a loss of $11.2 million in the prior year.Net Loss: $7.6 million or a loss of $0.25 per fully diluted share, compared to a net loss of $8.9 million or a loss of $0.31 per fully diluted share in the prior year.Cash Position: $44.9 million in cash, cash equivalents, and marketable investment securities.GuruFocus has detected 5 Warning Signs with CODX.Co-Diagnostics Inc  showcased their Co-Dx PCR platform at major trade shows, strengthening relation","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/gY1zAyP_yM8I1zhtICTwBw--~B/aD0yNDM7dz0yNDM7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/ba002a6338b45ced3986505d6cb81cff","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/gY1zAyP_yM8I1zhtICTwBw--~B/aD0yNDM7dz0yNDM7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/ba002a6338b45ced3986505d6cb81cff"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/co-diagnostics-inc-codx-q2-215844126.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CODX"],"gpt_icon":0},{"id":"2472434526","title":"Co-Diagnostics, Inc. to Host Booth at the 2024 UHCA/UCAL Fall Convention & Expo on Oct 2-3","url":"https://stock-news.laohu8.com/highlight/detail?id=2472434526","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472434526?lang=en_us&edition=fundamental","pubTime":"2024-10-02 21:30","pubTimestamp":1727875800,"startTime":"0","endTime":"0","summary":"SALT LAKE CITY, Oct. 2, 2024 /PRNewswire/ -- Co-Diagnostics, Inc.  , a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that Co-Diagnostics will be hosting a booth at the Utah Health Care Association/Utah Center for Assisted Living  Convention & Expo at the Mountain America Expo Center in Sandy, Utah on October 2-3, 2024.The UHCA/UCAL Convention includes sessions and events for executive leadership, administrators, corporate personnel, owners, and Directors of Nursing for skilled nursing, assisted living and intermediate care facilities, and will include an expo for companies to exhibit their products and services relevant to these industries. The Co-Dx booth will showcase the Company's upcoming Co-Dx PCR platform*, including the menu of at-home and point-of-care tests in development.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/KX2Pnj8YuhduS5XB_xAscA--~B/aD0xODQ7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/7a89e790bf1cbdd13a473c00e9766ccb","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/KX2Pnj8YuhduS5XB_xAscA--~B/aD0xODQ7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/7a89e790bf1cbdd13a473c00e9766ccb"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/co-diagnostics-inc-host-booth-133000562.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/co-diagnostics-inc-host-booth-133000562.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CODX","HST","BK4218","BK4568","BK4588","BK4181","BK4585","BK4082"],"gpt_icon":0},{"id":"2469491901","title":"Co-Diagnostics, Inc. to Accompany Utah Governor and WTC Utah on Trade Mission to South Korea and Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2469491901","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2469491901?lang=en_us&edition=fundamental","pubTime":"2024-09-24 21:30","pubTimestamp":1727184600,"startTime":"0","endTime":"0","summary":"SALT LAKE CITY, Sept. 24, 2024 /PRNewswire/ --Co-Diagnostics, Inc., a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced Company representatives will be accompanying Utah Governor Cox and the Governor's Office of Economic Opportunity, as part of the latest World Trade Center  Utah trade mission to South Korea and Japan from September 24-October 5.Co-Dx will join the delegation for life sciences and innovation, aiming to expand its international relationships. The company announced the creation of a joint venture in India in 2017 called CoSara Diagnostics Pvt. Ltd. and has also developed a robust portfolio of distributors, partners and customers in more than 50 countries during the pandemic years when Co-Diagnostics distributed millions of COVID-19 PCR tests globally. The WTC trade mission comes as Co-Dx is strengthening global relationships in preparation for introducing a new PCR diagnostic platform designe","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/KX2Pnj8YuhduS5XB_xAscA--~B/aD0xODQ7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/7a89e790bf1cbdd13a473c00e9766ccb","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/KX2Pnj8YuhduS5XB_xAscA--~B/aD0xODQ7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/7a89e790bf1cbdd13a473c00e9766ccb"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/co-diagnostics-inc-accompany-utah-133000877.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/co-diagnostics-inc-accompany-utah-133000877.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4568","CODX","BK4082"],"gpt_icon":0},{"id":"2465627314","title":"Market Today: Bitcoin Slumps, Coinbase Faces Regulatory Pressure, and Tesla Shines","url":"https://stock-news.laohu8.com/highlight/detail?id=2465627314","media":"GuruFocus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2465627314?lang=en_us&edition=fundamental","pubTime":"2024-09-07 05:11","pubTimestamp":1725657088,"startTime":"0","endTime":"0","summary":"Market Overview September started on a downbeat note for the stock market. The major indices all registered sizable declines during this holiday-shortened week. Broad selling activity led the S&P 500 ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gurufocus.com/news/2518539/market-today-bitcoin-slumps-coinbase-faces-regulatory-pressure-and-tesla-shines","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gurufocus_highlight","symbols":["LU0466842654.USD","LU2087621335.USD","LU0097036916.USD","APDN","BK4121","BK4112","BK4511","COIN","LU0820561818.USD","SG9999015986.USD","SMCI","LU2756315664.SGD","TSLL","BK4533","03439","LU1720051017.SGD","CODX","LU0943347566.SGD","03008","BK4535","LU1551013342.USD","BK4516","LU0689472784.USD","03042","SG9999015978.USD","LU1839511570.USD","83042","LU1861558580.USD","BK4583","TSLA","09042","LU0820561909.HKD","BK4082","BK4554","LU1861559042.SGD","BK4534","BK4555","BK4099","LU1551013425.SGD","LU2249611893.SGD","BK4548","09439","AVGO","LU2756315318.SGD","LU0964807845.USD","09008","LU2357305700.SGD","SBUX","BK4550"],"gpt_icon":1},{"id":"2465621851","title":"Applied DNA stock jumps amid U.S. government mpox update","url":"https://stock-news.laohu8.com/highlight/detail?id=2465621851","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2465621851?lang=en_us&edition=fundamental","pubTime":"2024-09-07 03:45","pubTimestamp":1725651948,"startTime":"0","endTime":"0","summary":"Applied DNA Sciences  shares rose 17% in afternoon trading Friday after U.S. officials said the government was stepping up surveillance of the mpox virus in response to an ongoing outbreak in Africa. Also rising were shares of fellow mpox test maker Co-Diagnostics , which edged up 2%.  Other makers of mpox detection products include Abbott  and Roche . Earlier Friday, U.S. officials said during a briefing that the government was expanding surveillance along with access to mpox testing and vaccines amid an ongoing outbreak of the disease overseas. It added that no new cases of a more easily transmissible strain of the virus have been confirmed in the U.S., according to Reuters. Mpox, which is related to smallpox, is also known as monkeypox.","market":"hk","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2166741669/image_2166741669.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2166741669/image_2166741669.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4147758-applied-dna-stock-jumps-amid-us-government-mpox-update","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["LU1057294990.SGD","LU1914381329.SGD","TQQQ","03165","LU1989763690.USD","BK4533","LU2468319806.SGD","ABT","SGXZ23171101.USD","LU1023059063.AUD","LU2089984988.USD","BK4592","APDN","CODX","BK4581","QLD","IE00BFTCPJ56.SGD","BK4007","BK4504","NQmain","BK4566","LU1989763427.SGD","BK4082","LU0170899867.USD","IE0002141913.USD","SQQQ","SG9999002224.SGD","BK4121","LU0266013472.USD","LU0122379950.USD",".IXIC","IE0009355771.USD","LU0868494617.USD","IE00BJJMRZ35.SGD","DNA","BK4109","SG9999004303.SGD","LU1691799644.USD","PSQ","QID","IE00B2B36J28.USD","IE00BJT1NW94.SGD","BK4588","MNQmain","BK4139","RHHBY","BK4583","SG9999002232.USD","BK4585"],"gpt_icon":1},{"id":"2465296345","title":"Bavarian Nordic stock slides on Moderna mpox vaccine study","url":"https://stock-news.laohu8.com/highlight/detail?id=2465296345","media":"seekingalpha","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2465296345?lang=en_us&edition=fundamental","pubTime":"2024-09-05 23:05","pubTimestamp":1725548745,"startTime":"0","endTime":"0","summary":"Bavarian Nordic’s  European listed shares were down around 7% Thursday morning, the day after a published study showed that a mpox vaccine being developed by Moderna  appeared to be more effective in preventing severe disease than Bavarian’s mpox vaccine Jynneos. The study, which was published online in the scientific journal Cell, evaluated Moderna’s mpox vaccine candidate mRNA-1769 and Jynneos in non-human primates. Results showed that while both vaccines were able to prevent death from the disease, primates that were given mRNA-1769 developed fewer lesions and other serious symptoms.  Demand for vaccines that can protect against mpox, also known as monkeypox, has dramatically increased in recent weeks due to a prolonged outbreak in Africa. Other companies working on vaccines or treatments for the disease include Emergent BioSolutions , Chimerix , Aspen Pharmacare , GeoVax Labs , SIGA Technologies  and Tonix Pharmaceuticals . Companies making tests for the disease include Co-Diagnost","market":"hk","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1402040044/image_1402040044.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1402040044/image_1402040044.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4147363-bavarian-nordic-stock-slides-on-moderna-mpox-vaccine-study","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["LU2468319806.SGD","RHHBY","LU1989763690.USD","IE0002141913.USD","LU2237957902.USD","BK4121","BK6520","LU0868494617.USD","LU1023059063.AUD","BK4566","BK6045","03165","LU0122379950.USD","LU1057294990.SGD","BK4532","LU1691799644.USD","IE00BFTCPJ56.SGD","BVNKF","LU1989763427.SGD","RHHBF","CODX","ABT","BK4568","LU1914381329.SGD","BK4592","SIGA","CMRX","EBS","BK4583","SG9999002232.USD","MRNA","BK4504","SG9999002224.SGD","IE00B2B36J28.USD","BK4551","BK4581","LU2089984988.USD","APNHF","SG9999004303.SGD","IE00BJT1NW94.SGD","LU0266013472.USD","BK4007","LU0234572021.USD","GOVX","IE00BJJMRZ35.SGD","MR7.SI","LU0170899867.USD","BK4585","APDN","TNXP"],"gpt_icon":1},{"id":"2465286075","title":"BRIEF-Co-Diagnostics, Inc. Completes Updated Clade Ib Analysis Of 2-Gene Mpox Ruo Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2465286075","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2465286075?lang=en_us&edition=fundamental","pubTime":"2024-09-05 22:28","pubTimestamp":1725546481,"startTime":"0","endTime":"0","summary":"Co-Diagnostics Inc   :   * CO-DIAGNOSTICS, INC. COMPLETES UPDATED CLADE IB ANALYSIS OF 2-GENE MPOX RUO TEST   * CO-DIAGNOSTICS: RESULTS OF ANALYSIS SHOW TEST SHOULD RETAIN FULL REACTIVITY AGAINST MPOX STRAINS CIRCULATING OVER LAST YEAR, INCLUDING CLADE 1BSource text for Eikon:    Further company coverage:","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4568","CODX"],"gpt_icon":0},{"id":"2465544282","title":"Co-Diagnostics: Results of Analysis Show Test Should Retain Full Reactivity Against Mpox Strains Circulating Over Last Year, Including Clade 1B","url":"https://stock-news.laohu8.com/highlight/detail?id=2465544282","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2465544282?lang=en_us&edition=fundamental","pubTime":"2024-09-05 21:30","pubTimestamp":1725543009,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240905:nFWN3KN1HT:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CODX","BK4568","BK4082"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.codiagnostics.com","stockEarnings":[{"period":"1week","weight":-0.0364},{"period":"1month","weight":-0.1654},{"period":"3month","weight":-0.3943},{"period":"6month","weight":0},{"period":"1year","weight":-0.1587},{"period":"ytd","weight":-0.203}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":0.436309},{"month":2,"riseRate":0.285714,"avgChangeRate":0.321589},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.14957},{"month":4,"riseRate":0.285714,"avgChangeRate":-0.009915},{"month":5,"riseRate":0.428571,"avgChangeRate":0.092054},{"month":6,"riseRate":1,"avgChangeRate":0.108385},{"month":7,"riseRate":0.714286,"avgChangeRate":0.208538},{"month":8,"riseRate":0.375,"avgChangeRate":-0.109957},{"month":9,"riseRate":0.25,"avgChangeRate":-0.032163},{"month":10,"riseRate":0.25,"avgChangeRate":-0.046183},{"month":11,"riseRate":0.25,"avgChangeRate":-0.051394},{"month":12,"riseRate":0.285714,"avgChangeRate":-0.152794}],"exchange":"NASDAQ","name":"Co-diagnostics Inc.","nameEN":"Co-diagnostics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Co-diagnostics Inc.(CODX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Co-diagnostics Inc.(CODX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Co-diagnostics Inc.,CODX,Co-diagnostics Inc.股票,Co-diagnostics Inc.股票老虎,Co-diagnostics Inc.股票老虎国际,Co-diagnostics Inc.行情,Co-diagnostics Inc.股票行情,Co-diagnostics Inc.股价,Co-diagnostics Inc.股市,Co-diagnostics Inc.股票价格,Co-diagnostics Inc.股票交易,Co-diagnostics Inc.股票购买,Co-diagnostics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Co-diagnostics Inc.(CODX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Co-diagnostics Inc.(CODX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}